Kim Janda

Insider Reports History

Entity
Individual
Location
6042 Cornerstone Ct. West, Suite B, San Diego, CA
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Janda:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sorrento Therapeutics, Inc. Director Common Stock 3K $2.41K $0.80 Dec 27, 2021 Direct
Sorrento Therapeutics, Inc. Director Non-qualified stock option 0 Dec 27, 2021 Direct

Insider Reports Filed by Kim Janda

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRNEQ Sorrento Therapeutics, Inc. Dec 31, 2021 1 -$31.3K 5 Feb 6, 2023 Director
SRNEQ Sorrento Therapeutics, Inc. Dec 27, 2021 3 -$5.64K 4 Dec 27, 2021 Director
SRNEQ Sorrento Therapeutics, Inc. Sep 27, 2021 5 -$250K 4 Sep 28, 2021 Director
SRNEQ Sorrento Therapeutics, Inc. Sep 13, 2021 3 -$36.3K 4 Sep 14, 2021 Director
SRNEQ Sorrento Therapeutics, Inc. Aug 30, 2021 1 $0 4 Aug 30, 2021 Director